MBRS-18. TUMOR SUPPRESSOR p53 DEFINES THE THERAPEUTIC RESPONSES IN TREATMENT OF MEDULLOBLASTOMA

Medulloblastoma (MB) is the most common primary pediatric malignant brain tumor. Current molecular analysis classifies MB into 4 groups, classic (WNT), sonic hedgehog (Shh), group 3, and group 4. Furthermore, atypical p53 signaling is associated with disease progression and confers poor prognosis. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Avinash L, Amin, Anubhav G, Tobias, Michael E, Das, Mohan K, de Medeiros, Raphael S S, Zanon, Nelci, Gandhi, Chirag D, Epelman, Sidnei, Jhanwar-Uniyal, Meena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Research)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715667/
http://dx.doi.org/10.1093/neuonc/noaa222.534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715667/
http://dx.doi.org/10.1093/neuonc/noaa222.534

Ejemplares similares